We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
10 Year Est. Return
AUM
$92.4M
AUM Growth
-$24.2M
Cap. Flow
-$14.9M
Cap. Flow %
-16.14%
Top 10 Hldgs %
40.1%
Holding
400
New
Increased
65
Reduced
21
Closed
286

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$647K
2
HBAN icon
Huntington Bancshares
HBAN
+$175K
3
DHR icon
Danaher
DHR
+$142K
4
U icon
Unity
U
+$108K
5
XYZ
Block Inc
XYZ
+$105K

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$570K
2
TER icon
Teradyne
TER
+$296K
3
XYL icon
Xylem
XYL
+$293K
4
SPOT icon
Spotify
SPOT
+$234K
5
RBLX icon
Roblox
RBLX
+$233K

Sector Composition

Rank Sector Weight
1 Technology 51.09%
2 Healthcare 13.04%
3 Consumer Discretionary 9.43%
4 Financials 7.08%
5 Communication Services 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
126
Applied Materials
AMAT
$428B
-300
Closed -$47K
AMP icon
127
Ameriprise Financial
AMP
$48.8B
-130
Closed -$39K
AMT icon
128
American Tower
AMT
$80.4B
-440
Closed -$128K
APD icon
129
Air Products & Chemicals
APD
$67.6B
-275
Closed -$83K
API
130
Agora
API
$377M
-100
Closed -$1K
APPN icon
131
Appian
APPN
$2.48B
-2,450
Closed -$159K
APTV icon
132
Aptiv
APTV
$10.3B
-500
Closed -$82K
AQB icon
133
AquaBounty Technologies
AQB
$6.02M
-3
Closed
ARCT icon
134
Arcturus Therapeutics
ARCT
$211M
-1,400
Closed -$51K
ARKG icon
135
ARK Genomic Revolution ETF
ARKG
$1.73B
-192
Closed -$11K
ARKK icon
136
ARK Innovation ETF
ARKK
$6.31B
-70
Closed -$6K
ASIX icon
137
AdvanSix
ASIX
$444M
-989
Closed -$46K
ASML icon
138
ASML
ASML
$669B
-24
Closed -$19K
ASPN icon
139
Aspen Aerogels
ASPN
$518M
-2,700
Closed -$134K
AZN icon
140
AstraZeneca
AZN
$250B
-150
Closed -$17K
BABA icon
141
Alibaba
BABA
$308B
-668
Closed -$79K
BAX icon
142
Baxter International
BAX
$14.2B
-1,078
Closed -$92K
BBY icon
143
Best Buy
BBY
$17.3B
-101
Closed -$10K
BHC icon
144
Bausch Health
BHC
$2.34B
-2,500
Closed -$69K
BHP icon
145
BHP
BHP
$230B
-392
Closed -$21K
BIIB icon
146
Biogen
BIIB
$30.7B
-3
Closed
BLD
147
DELISTED
TopBuild
BLD
-421
Closed -$116K
BLK icon
148
Blackrock
BLK
$176B
-254
Closed -$233K
BNTX icon
149
BioNTech
BNTX
$23.5B
-100
Closed -$25K
BSV icon
150
Vanguard Short-Term Bond ETF
BSV
$44.6B
-315
Closed -$25K

Similar funds

KRS Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, KRS Capital Management held 400 positions worth $92.4M, down 21% from $117M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

KRS Capital Management withdrew a net $14.9M in Q1 2022, closing 286 positions and reducing 21 holdings. Its most notable exit was Xilinx Inc, an estimated $570K position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, KRS Capital Management added an estimated $647K to Advanced Micro Devices.

  • KRS Capital Management added most to Advanced Micro Devices in Q1 2022, an estimated $647K increase.
  • KRS Capital Management's biggest Q1 2022 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $139K.
  • KRS Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $570K.
  • KRS Capital Management's ten largest holdings make up 40% of its $92.4M portfolio in Q1 2022.
  • KRS Capital Management opened 0 new positions and closed 286 in Q1 2022.
  • KRS Capital Management's portfolio value fell 21% quarter-over-quarter to $92.4M.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.